(Date:8/21/2008)... IL, Aug. 21 /PRNewswire-FirstCall/ - SXC Health S...SXCI , TSX: SXC), a leading provider of,pharmacy b...hierer,President and CEO, and Jeff Park, CFO, wil...hcare Conference at the Four Seasons Hotel in Bost...ace on Wednesday, September,3, 2008 at 2:40 pm ET....
(Date:8/21/2008)... Flu Vaccination Awareness Campaign...Electing a President is Not the Only Important Cho...aithersburg, MD (PRWEB) August 21, 2008 -- A new s...at vaccination ranks next to last among things the...influenza virus. Although public health guidelines...
(Date:8/21/2008)...ous Coalition for Reproductive Choice at the Democ...RNewswire-USNewswire/ -- RCRC -- the Religious,Coa...ents at the Democratic,National Convention to high...s in the campaign. RCRC,s president, The Reverend ...d is also available for media,interviews. RCRC is ...
(Date:8/21/2008)...IA BEACH, Va., Aug. 21, 2008 /PRNewswire/ -- The A...p. Sylvester Turner of Houston has,been honored wi...is part of the AMERIGROUP Foundation,s national pr...rts by government and community,leaders in improvi...t our,nation., "Our goal is to work together with...
Breaking Medicine News(10 mins):Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 2Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 3Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 4Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 5Health News:Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation 2(Date:8/20/2008)...ileCampus(TM) Wireless Data Communications Link Sc... Faculty, WALL, N.J., Aug. 20 /PRNewswire-FirstCa...ard: BKYI), a leader in finger-based biometric,ide...today announced the,availability of MobileSRO(TM) ...rt and management solutions for K-12 schools and h...
(Date:8/20/2008)...Capital Leads Round with Additional Funding by Syn...ing Investors Including Lockheed Martin, GE Sec...RK, Aug. 20 /PRNewswire/ -- Clear(R), the fast pas...in venture funding. Led by new investor,Spark Capi...ncom Venture,Partners, and existing investors Lock...
(Date:8/20/2008)...mony watermelon? How about a strawberry-flavored b...cal School at Houston say the day may be coming wh...sponsible for flavors in fruits and vegetables. In...ly pest control. , In the advance online publica...istant Professor C.S. Raman, Ph.D., and his collea...
(Date:8/20/2008)...nd. - Engineers have created a tiny motorized ,po...imilar devices being ,developed for applications ..., powerful computer hard drives. , The device, c...,"nanoscale manipulator" that precisely moves or ... be used in watery environments for probing ,biol...
Breaking Biology News(10 mins):BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3Clear(R) Secures $44.4 Million in Venture Funding 2Clear(R) Secures $44.4 Million in Venture Funding 3Biochemists manipulate fruit flavor enzymes 2New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 1Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 2Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 4Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 5Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 20754 1Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 20754 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 1Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 3Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 4Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 5Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 1Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 2Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 3Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 4